This article talks about a company called Viking Therapeutics and how some people are trading options on it. Options are a way to bet on the future of a stock, but they can be risky. The article also mentions that different analysts have given different ratings and target prices for the company's stock. If someone wants to follow these trades closely, they can use Benzinga Pro, which sends alerts when there are new options trades. Read from source...

- The title is misleading and clickbaity. It does not reflect the actual content of the article which is mostly about analyst ratings and options trades for Viking Therapeutics.
- The article does not provide any original or insightful information about the company's latest developments, pipeline, clinical trials, financial performance, etc. It only cites existing sources such as Benzinga Pro, Raymond James, HC Wainwright & Co., and others.
- The article uses vague terms like "behind the scenes" and "options trends" without explaining what they mean or how they are relevant to the company's prospects.